WHO prequalifies infant malaria treatment amid systemic gaps in equitable access and prevention

Indigenous and traditional knowledge systems have historically provided effective, low-cost malaria prevention and treatment strategies, such as the use of *Artemisia annua* (sweet wormwood) in Chinese and African medicine, which predates modern antimalarials by millennia. These systems emphasize holistic health, environmental stewardship, and community-based care, yet they are systematically excluded from global health policy frameworks. The WHO's approval of a pharmaceutical solution without parallel investment in indigenous-led prevention programs reflects a continued devaluation of traditional knowledge in favor of industrialized medicine.

Malaria has been a defining disease of colonial expansion, with European colonizers inadvertently spreading the disease while exploiting labor in endemic regions like Sub-Saharan Africa and South Asia. The WHO's 1955 Global Malaria Eradication Program, though initially successful in some regions, collapsed due to a lack of sustained funding and the emergence of insecticide resistance, mirroring today's fragmented approach to malaria control. Historical parallels also include the 19th-century quinine trade, which was controlled by European powers, underscoring how geopolitical power structures shape disease management and access to treatment.

Cross-culturally, malaria is often framed as a disease of poverty and environmental degradation, with indigenous communities in the Amazon and Southeast Asia developing unique adaptive strategies, such as burning specific plants to repel mosquitoes or using fish to control larval populations. In contrast, Western public health approaches prioritize pharmaceutical interventions, which, while effective, are often inaccessible to the poorest populations. Collaborative models, such as those in Vietnam where traditional medicine is integrated into national health programs, demonstrate the potential for culturally resonant solutions.

Scientifically, the WHO's prequalification of artemether-lumefantrine for infants is a milestone in pediatric pharmacology, addressing a critical gap in malaria treatment where dosing for young children was previously unstandardized. However, the focus on pharmaceutical solutions overlooks the scientific evidence supporting integrated vector management, such as the use of gene-drive mosquitoes to suppress populations or the deployment of Wolbachia-infected mosquitoes to block transmission. Additionally, the rise of artemisinin resistance in Southeast Asia poses a looming threat to the efficacy of current treatments, highlighting the need for diversified approaches.

Artistically and spiritually, malaria has been mythologized in many cultures as a curse, a test of resilience, or a force to be negotiated with through rituals and offerings. In West African traditions, malaria is sometimes associated with ancestral spirits, and healing ceremonies may include drumming, dance, and the burning of specific herbs to cleanse the environment. These practices, though often dismissed as superstition, reflect a deep ecological awareness of the interconnectedness between human health and the natural world, which modern medicine could learn from.

Future modelling of malaria control must account for the compounding effects of climate change, which is expanding the geographic range of *Anopheles* mosquitoes and increasing transmission seasons in high-altitude regions. Scenario planning should prioritize adaptive strategies, such as climate-resilient housing designs, community-led surveillance systems, and the development of next-generation vaccines that do not require cold chains. Additionally, models must incorporate the economic and social costs of inaction, including the long-term impacts of childhood malaria on cognitive development and economic productivity in endemic regions.

Marginalized voices—particularly those of African women, who are primary caregivers for malaria-stricken children—are systematically excluded from global health policy discussions, despite bearing the brunt of the disease's burden. Indigenous communities, who have the most intimate knowledge of local ecosystems and disease patterns, are rarely consulted in the design of malaria control programs. The lack of representation in decision-making processes ensures that solutions remain top-down and technocratic, rather than community-driven and culturally appropriate.